in which the prognostic impact of different molecular aberrations in CMML patients was studied, only ASXL1 mutations retained their significant impact on AML-free survival in the multivariate analysis indicating the major role of this molecular aberration in the transformation process (9). The gene discussed is ASXL1; the disease is chronic myelomonocytic leukemia.